[go: nahoru, domu]

Jump to content

Josephine Bunch

From Wikipedia, the free encyclopedia
Josephine Bunch
Alma materSheffield Hallam University
Scientific career
InstitutionsNational Physical Laboratory (United Kingdom)

Imperial College London

University of Sheffield
ThesisDetection and imaging of pharmaceutical compounds in skin by MALDI-MS (2005)

Josephine Bunch is a fellow at the National Physical Laboratory. She is Chair of Biomolecular Mass Spectrometry at Imperial College London and the Co-Director of the National Centre of Excellence in Mass Spectrometry Imaging.

Education

[edit]

Bunch completed a PhD sponsored by Pfizer at Sheffield Hallam University in 2005.[1] Her thesis, "Detection and imaging of pharmaceutical compounds in skin by MALDI-MS", used mass spectrometry.[2]

Research

[edit]

Bunch was a postdoctoral researcher at the University of Sheffield, where she was awarded an Enterprise Fellowship to commercialise imaging using mass spectrometry.[1] She joined the University of Birmingham, leading a large multi-disciplinary group using MALDI Mass spectrometry.[3][4] She remains an honorary senior research fellow at the University of Birmingham.[5] She also holds a Chair in Biomolecular Mass Spectrometry at Imperial College London.[6]

She joined the National Physical Laboratory in 2013, where she became responsible for research in MALDI metrology.[4][7] In 2017 Bunch was funded by Cancer Research UK's Grand Challenge to map tumours at a molecular and cellular level.[8] She came up with the idea when listening to a BBC Radio 4 program about the Cancer Research UK Grand Challenges.[9] The investment was worth £16 million, and uses mass spectrometry imaging techniques to study breast, bowel and pancreatic tumours in "unprecedented detail.[10][11][12][13][14] She spoke about the project at the Hay Festival and presented their project at the Royal Society Summer Exhibition.[15][16][17]

She is part of a COST (European Cooperation in Science and Technology) Action on mass spectrometry imaging.[18][3]

References

[edit]
  1. ^ a b "Josephine Bunch : People : National Physical Laboratory". www.npl.co.uk. Retrieved 2018-05-20.
  2. ^ Josephine., Bunch (2005). "Detection and imaging of pharmaceutical compounds in skin by MALDI-MS". shura.shu.ac.uk. Retrieved 2018-05-20.
  3. ^ a b "COST | Mass Spectrometry Imaging: New Tools for Healthcare Research". www.cost.eu. Retrieved 2018-05-20.
  4. ^ a b "Dr Josephine Bunch has been appointed to lead research in MALDI metrology and fundamentals at NICE-MSI - The University of Nottingham". www.nottingham.ac.uk. Retrieved 2018-05-20.
  5. ^ "Dr Josephine Bunch, Chemistry - University of Birmingham". www.birmingham.ac.uk. Retrieved 2018-05-20.
  6. ^ "A-Z People". Imperial College London. Retrieved 2018-05-20.
  7. ^ SelectScience (2017-07-21), Mass Spec Imaging Enables Greater Understanding of Tumors Than Ever Before, retrieved 2018-05-20
  8. ^ "Building a 'Google Earth' of cancer : National Physical Laboratory". www.npl.co.uk. Retrieved 2018-05-20.
  9. ^ Barker, Charlotte (2017). "A Google Earth View of Cancer" (PDF). The Analytical Scientist. Retrieved 2018-05-20.
  10. ^ "Funded team Bunch". Cancer Research UK. 2017-02-02. Retrieved 2018-05-20.
  11. ^ "Grand Challenge: The Research : Building a 'Google Earth' of cancer : National Physical Laboratory". www.npl.co.uk. Retrieved 2018-05-20.
  12. ^ "Cartographers of Cancer". The Analytical Scientist. Retrieved 2018-05-20.
  13. ^ "'Google Earth' for tumours could change cancer treatment forever". Metro. 2017-03-09. Retrieved 2018-05-20.
  14. ^ "'Google Earth' For Tumours Could Change Cancer Diagnostics And Drug Testing Forever". HuffPost UK. 2017-03-20. Retrieved 2018-05-20.
  15. ^ "Mapping cancer's secret chemistry". royalsociety.org. Retrieved 2018-05-20.
  16. ^ Hay Levels (2017-10-17), CHEMISTRY - Mass Spectrometry - Josephine Bunch, retrieved 2018-05-20
  17. ^ hayfestival. "CHEMISTRY - Mass Spectrometry - Josephine Bunch". TES Resources. Retrieved 2018-05-20.
  18. ^ "COST | Who's Who". www.cost.eu. Retrieved 2018-05-20.